Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults.

J R Soc Med · 2023 · PMC10686205 · PMID 37404021

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

During the Alpha dominance, all three measured outcomes showed a trend towards a poorer prognosis for SARS-CoV-2 AECOPD than those with exacerbations caused by other infectious agents, with statistical significance only demonstrated for increased 30-day mortality risk in SARS-CoV-2 AECOPD versus non-SARS-CoV-2 infection AECOPD.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.